These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12848769)

  • 21. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists.
    Campbell DJ
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S125-31. PubMed ID: 8993851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
    Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
    J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
    Maillard MP; Perregaux C; Centeno C; Stangier J; Wienen W; Brunner HR; Burnier M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1089-95. PubMed ID: 12183667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
    Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
    J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay.
    Belz GG; Butzer R; Kober S; Mang C; Mutschler E
    Clin Pharmacol Ther; 1999 Oct; 66(4):367-73. PubMed ID: 10546920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects.
    Regitz-Zagrosek V; Neuss M; Fleck E
    Eur Heart J; 1995 Dec; 16 Suppl N():86-91. PubMed ID: 8682068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and hormonal effects of the new angiotensin II receptor antagonist LRB081.
    Noël B; Del Re G; Capone P; Brunner HR; Nussberger J
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):252-8. PubMed ID: 8856481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
    Hilditch A; Hunt AA; Gardner CJ; Twissell DJ; Polley J; Travers A; Drew GM; Middlemiss D; Ross BC; Robertson MJ
    Br J Pharmacol; 1994 Jan; 111(1):137-44. PubMed ID: 8012689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel angiotensin receptor subtypes in fowl.
    Nishimura H; Walker OE; Patton CM; Madison AB; Chiu AT; Keiser J
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
    Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T
    J Pharmacol Exp Ther; 2001 Jul; 298(1):62-70. PubMed ID: 11408526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
    Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
    Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F; Al-Jarallah A; Joseph S
    PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
    Cervenka L; Wang CT; Navar LG
    Am J Physiol; 1998 May; 274(5):F940-5. PubMed ID: 9612332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candesartan, an Insurmountable Antagonist of Angiotensin II-mediated Contractile Effects in Isolated Vascular Preparations: Comparison with Irbesartan, Losartan and its Active Metabolite (EXP-3174).
    Morsing U Brandt-Eliasson L Renberg T Abrahamsson P
    Blood Press; 2000; 9(sup1):50-51. PubMed ID: 28425810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin system.
    Buchwalder-Csajka C; Buclin T; Brunner HR; Biollaz J
    Br J Clin Pharmacol; 1999 Oct; 48(4):594-604. PubMed ID: 10583031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries.
    Ytterberg H; Edvinsson L
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S37-S41. PubMed ID: 28095233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.